XML 62 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information
12 Months Ended
Sep. 30, 2013
Segment Information [Abstract]  
Segment Information

16.   Segment Information

The Company changed the presentation of its reporting segments to separately disclose certain ‘corporate expenses’ that had previously been reported within the Radiation Measurement segment.  As a result, the current segment disclosures have been retrospectively adjusted to reflect three reporting segments, Radiation Measurement, Medical Physics and Medical Products and one functional group: Corporate. The factors for determining the reportable segments reflect specific markets and the products and services offered combined with the nature of the individual business traits, as well as key financial information reviewed by management.

 

The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure. These services are provided internationally primarily to hospitals, medical and dental offices, universities, national laboratories, and nuclear facilities. Radiation Measurement activities include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. In addition to providing analytical services, the Radiation Measurement segment leases or sells dosimetry detectors and reading equipment.

 

The Medical Physics segment provides therapeutic and imaging physics services to domestic hospitals and radiation therapy centers. Service offerings include clinical physics support, equipment commissioning, accreditation support and imaging equipment testing. These professional services are provided to customers on-site by skilled physicists. Medical physics services are provided through the Company’s LMP subsidiary.

 

The Medical Products segment provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures. Medical products range from consumables used with MRI, CT, and mammography technologies to highly engineered passive reflective markers used during image guided surgery procedures. Medical Products sales are provided through the Company’s IZI subsidiary.

 

The Company primarily evaluates performance of the individual segments based upon, among other metrics, segment operating income or loss. Segment operating income or loss is segment revenues less segment cost of sales and segment selling, general and administrative expenses. Corporate expenses for shared functions, including corporate management, corporate finance and human resources, are recognized in the Corporate functional group. In addition, acquisition and reorganization costs are not allocated to the segments. Information about net other income, including interest income and expense, and income taxes is not provided at the segment level. As the Company’s business model evolves in increased complexity, management may determine it necessary to change this reporting practice to reflect any appropriate allocations.

 

The following tables summarize financial information for each reportable segment for the years ended September 30:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

(Dollars in Thousands)

 

Radiation 
Measurement

 

Medical 
Physics

 

Medical 
Products

 

 

Corporate

 

Consolidated

Revenues

 

$

109,836 

 

$

30,859 

 

$

9,505 

 

$

 -

 

$

150,200 

Operating income (loss)(1)

 

 

39,319 

 

 

3,507 

 

 

(21,828)

 

 

(16,878)

 

 

4,120 

Depreciation and amortization

 

 

11,180 

 

 

1,185 

 

 

2,559 

 

 

 -

 

 

14,924 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2012

(Dollars in Thousands)

 

Radiation 
Measurement

 

Medical 
Physics

 

Medical 
Products

 

 

Corporate

 

Consolidated

Revenues

 

$

107,922 

 

$

30,937 

 

$

13,541 

 

$

 -

 

$

152,400 

Operating income (loss)

 

 

43,775 

 

 

1,334 

 

 

5,297 

 

 

(22,236)

 

 

28,170 

Depreciation and amortization

 

 

8,377 

 

 

1,419 

 

 

1,835 

 

 

 -

 

 

11,631 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2011

(Dollars in Thousands)

 

Radiation 
Measurement

 

Medical 
Physics

 

Medical 
Products

 

 

Corporate

 

Consolidated

Revenues

 

$

99,868 

 

$

20,590 

 

$

 -

 

$

 -

 

$

120,458 

Operating income (loss)

 

 

48,208 

 

 

(490)

 

 

 -

 

 

(12,835)

 

 

34,883 

Depreciation and amortization

 

 

7,032 

 

 

959 

 

 

 -

 

 

 -

 

 

7,991 

 

(1)Fiscal 2013 includes $22,700 impairment charge.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in Thousands)

 

2013

 

2012

Segment assets:

 

 

 

 

 

 

Radiation Measurement

 

$

170,648 

 

$

171,831 

Medical Physics

 

 

35,218 

 

 

36,304 

Medical Products

 

 

70,967 

 

 

93,990 

Total assets

 

$

276,833 

 

$

302,125